[PLX] QoQ Quarter Result on 30-Jun-2010 [#Q2]

Stock
[PLX] Protalix BioTherapeutics, Inc.
Announcement Date
05-Aug-2010
Financial Year
2010
Quarter
30-Jun-2010 [#Q2]
Profit Trend
QoQ- -26.22%
YoY- -85.02%
Quarter Report
PLX's Result
PLX's Financial Summary
View:
Show?
Quarter Result
31/03/11 31/12/10 30/09/10 30/06/10 31/03/10 31/12/09 30/09/09 CAGR
Revenue 6,000 1,176 3,184 1,141 1,141 388 0 -
PBT -5,052 22,414 0 0 -7,955 31,440 0 -
Tax 0 -20,470 -374 -109 0 -16,504 -152 -
NP -5,052 -8,528 -2,474 -10,041 -7,955 -14,936 -5,894 -9.77%
Tax Rate - 91.33% - - - 52.49% - -
Total Cost 11,052 9,704 5,658 11,182 9,096 15,324 5,894 52.12%
Ratio Analysis
31/03/11 31/12/10 30/09/10 30/06/10 31/03/10 31/12/09 30/09/09 CAGR
NP Margin -84.20 -725.17 -77.70 -880.02 -697.20 -3,849.48 0.00 -
Per Share
31/03/11 31/12/10 30/09/10 30/06/10 31/03/10 31/12/09 30/09/09 CAGR
EPS -0.06 -1.04 -0.03 -0.12 -0.10 -1.85 -0.08 -17.46%
EPS Diluted -0.06 -1.04 -0.03 -0.12 -0.10 -1.85 -0.08 -17.46%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.